Category: Top Story

  • Moderna Revenue Drops 45% but Still Beats Expectations; Guidance Trimmed

    Moderna Revenue Drops 45% but Still Beats Expectations; Guidance Trimmed

    Moderna (NASDAQ:MRNA) reported a steep decline in third-quarter revenue as demand for COVID-19 vaccines continued to fade, but the results still surpassed Wall Street estimates, supported by stronger-than-expected vaccine sales and lower costs. The biotechnology company posted revenue of $1.02 billion, down 45% year-over-year, yet comfortably ahead of analysts’ forecasts of $829.1 million. The better-than-expected…

  • TripAdvisor Tops Q3 Earnings Forecasts, Refocuses on Experiences-Led Growth

    TripAdvisor Tops Q3 Earnings Forecasts, Refocuses on Experiences-Led Growth

    TripAdvisor, Inc. (NASDAQ:TRIP) delivered third-quarter earnings that surpassed analyst expectations on Thursday, as the travel platform sharpened its focus on becoming an experiences-driven, AI-enhanced company. The company reported adjusted earnings per share of $0.65, beating Wall Street’s consensus estimate of $0.56. Revenue reached $553 million, slightly below the expected $562.92 million but still up 4%…

  • Krispy Kreme Shares Climb 7% as Turnaround Strategy Gains Early Traction

    Krispy Kreme Shares Climb 7% as Turnaround Strategy Gains Early Traction

    Shares of Krispy Kreme, Inc. (NASDAQ:DNUT) jumped 7.43% in premarket trading on Thursday after the company posted better-than-expected third-quarter earnings, signaling that its turnaround plan is beginning to take hold. The doughnut maker reported adjusted earnings of $0.01 per share, easily beating Wall Street’s forecast for a $0.06 loss. While revenue came in slightly below…

  • SharkNinja Shares Jump 11% After Blowing Past Q3 Estimates

    SharkNinja Shares Jump 11% After Blowing Past Q3 Estimates

    Shares of SharkNinja, Inc. (NYSE:SN) surged 11.07% in premarket trading on Thursday after the company delivered third-quarter results that handily beat Wall Street expectations, powered by strong performance across all major product categories. The global product design and technology company posted adjusted earnings of $1.50 per share, a massive $0.62 above the analyst consensus of…

  • Ascent Solar Shares Climb After Partnership with CisLunar Industries

    Ascent Solar Shares Climb After Partnership with CisLunar Industries

    Shares of Ascent Solar Technologies Inc. (NASDAQ:ASTI) rose 5% in premarket trading on Thursday after the company announced a teaming agreement with CisLunar Industries to co-develop next-generation power systems for space missions. Under the collaboration, the two Colorado-based firms will integrate Ascent’s thin-film photovoltaic technology with CisLunar’s high-efficiency power conversion systems to produce durable, energy-efficient…

  • Ducommun Shares Edge Higher as Q3 Earnings Beat Expectations and Defense Momentum Persists

    Ducommun Shares Edge Higher as Q3 Earnings Beat Expectations and Defense Momentum Persists

    Ducommun Inc. (NYSE:DCO) reported third-quarter results on Thursday that surpassed analyst forecasts, supported by another strong performance in its defense segment even as commercial aerospace activity remained under pressure. The company’s stock climbed 2.12% in premarket trading following the release. The aerospace and defense manufacturer posted adjusted earnings of $0.99 per share, topping the consensus…

  • Prestige Consumer Healthcare Beats Q2 Expectations and Raises EPS Guidance

    Prestige Consumer Healthcare Beats Q2 Expectations and Raises EPS Guidance

    Prestige Consumer Healthcare Inc. (NYSE:PBH) reported fiscal second-quarter 2026 results on Thursday that topped analyst estimates, as earnings outperformed expectations despite lingering supply challenges in its eye care division. The healthcare products maker posted adjusted earnings per share of $1.07, exceeding the consensus estimate of $0.97. Revenue came in at $274.1 million, above expectations of…

  • Haemonetics Shares Gain After Q2 Beat and Upgraded Full-Year Outlook

    Haemonetics Shares Gain After Q2 Beat and Upgraded Full-Year Outlook

    Haemonetics Corporation (NYSE:HAE) shares climbed 3% in premarket trading Thursday after the medical technology company posted strong fiscal second-quarter results that topped Wall Street expectations and prompted an upgrade to its full-year guidance. For the quarter ended September 27, Haemonetics reported adjusted earnings of $1.27 per share, beating the analyst consensus of $1.11. Revenue came…

  • YETI Lifts Profit Outlook After Q3 Earnings Beat, Narrows Sales Guidance

    YETI Lifts Profit Outlook After Q3 Earnings Beat, Narrows Sales Guidance

    YETI Holdings (NYSE:YETI) raised its full-year earnings forecast on Thursday after reporting third-quarter results that topped analyst expectations, supported by continued strength in its Coolers & Equipment segment despite softer Drinkware sales. The company posted earnings per share of $0.61, ahead of the $0.58 consensus estimate, while revenue grew 2% year over year to $487.8…

  • Titan International Rises as Q3 Results Beat Expectations on Strong Segment Growth

    Titan International Rises as Q3 Results Beat Expectations on Strong Segment Growth

    Titan International, Inc. (NYSE:TWI) shares edged 1.9% higher in premarket trading Thursday after the off-highway wheel and tire manufacturer posted third-quarter earnings and revenue that surpassed analyst forecasts, supported by solid performance across its agriculture and earthmoving/construction divisions. The company reported adjusted earnings of $0.04 per share, topping Wall Street’s estimate of a $0.03 loss.…